Package 45963-614-51

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 45963-614-51
Digits Only 4596361451
Product NDC 45963-614
Product ID 45963-614_8f2da07f-1d3e-4d8b-8083-805da8a780db
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2015-03-12
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "8f2da07f-1d3e-4d8b-8083-805da8a780db", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["5e1fdcaa-918f-4cd8-9c7a-4c538d866198"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "45963-614-51", "marketing_start_date": "20150312"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "45963-614-55", "marketing_start_date": "20150312"}], "brand_name": "Irinotecan hydrochloride", "product_id": "45963-614_8f2da07f-1d3e-4d8b-8083-805da8a780db", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "45963-614", "generic_name": "Irinotecan hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA078589", "marketing_category": "ANDA", "marketing_start_date": "20150312", "listing_expiration_date": "20261231"}